|
Ziltivekimab reduced inflammatory biomarkers associated with atherosclerosis in people with chronic kidney disease in phase 2 trial
https://www.novonordisk.com/content/nncorp/global/...ls.html?id=59583
Oramed
Oral insulin: Our proprietary flagship product, an orally ingestible insulin capsule, or ORMD-0801, allows insulin to travel from the gastrointestinal tract via the portal vein to the bloodstream, revolutionizing the manner in which insulin is delivered. It enables the passage in a more physiological manner than current delivery methods of insulin.
Phase III Trial: Based on guidance received from the FDA as part of the End-of-Phase 2 meeting process for our oral insulin candidate, ORMD-0801, we have submitted to the FDA the protocols for our upcoming pivotal Phase III studies.
The trial’s topline results are expected in 2022 and we anticipate filing a BLA with the FDA in 2023.
https://www.oramed.com/investors/sec-filings/
Denke die Entwicklung sollte im Auge behalten werden.
Hat jemand eine Meinung dazu?
Heartseed and Novo Nordisk enter into global collaboration and licence agreement for stem cell-based therapy for heart failure
https://www.novonordisk.com/content/nncorp/global/...ls.html?id=61691
Wegovy (semaglutide 2.4 mg), the first and only once-weekly GLP-1 therapy for weight management, approved in the US
https://www.ariva.de/news/...g-the-first-and-only-once-weekly-9552163
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
11 | 2.603 | Novo-Nordisk - Insulinpräparate | elNacho | mogge67 | 16.04.24 10:46 | |
30 | Das 1. Medikament, welches Alzheimer verbessert | Leronlimab | uranfakts | 22.09.22 21:26 | ||
15 | Dividenden-Giganten | dipling | Lalapo | 10.12.16 11:08 | ||
Thema Diabetis-Insulien | SonNegre | 23.02.15 17:50 |